ivabradine has been researched along with 3-hydroxy-3-methylglutaryl-coenzyme a in 1 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (3-hydroxy-3-methylglutaryl-coenzyme a) | Trials (3-hydroxy-3-methylglutaryl-coenzyme a) | Recent Studies (post-2010) (3-hydroxy-3-methylglutaryl-coenzyme a) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 408 | 12 | 176 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jasińska-Stroschein, M; Orszulak-Michalak, D; Owczarek, J | 1 |
1 other study(ies) available for ivabradine and 3-hydroxy-3-methylglutaryl-coenzyme a
| Article | Year |
|---|---|
Concomitant administration of different doses of simvastatin with ivabradine influence on PAI-1 and heart rate in normo- and hypercholesterolaemic rats.
Topics: Acyl Coenzyme A; Animals; Benzazepines; Blood Pressure; Cardiovascular Agents; Cholesterol; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ivabradine; Lipids; Male; Models, Statistical; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Risk Factors; Simvastatin | 2012 |